by CancerIQ, on Feb 27, 2020 10:14:31 AM
Hereditary cancer accounts for up to 10% of new cancer diagnoses. Although widespread adoption of affordable genetic testing is possible and highly valued, health systems struggle to identify candidates for …
Read StoryAt CancerIQ, we're dedicated to making it easier for providers to offer cancer risk assessment to every patient that walks through the door. This starts with practical implementation methods and tools (like CancerIQ)! On our blog, we'll offer best practices and advice on how to streamline your cancer risk assessment program.
515 N. State, Suite 1025
Chicago, IL 60654
Call us: 312-761-3360
info@cancer-iq.com